AU2002230965A8 - Methods for inhibiting fibrosis - Google Patents

Methods for inhibiting fibrosis

Info

Publication number
AU2002230965A8
AU2002230965A8 AU2002230965A AU2002230965A AU2002230965A8 AU 2002230965 A8 AU2002230965 A8 AU 2002230965A8 AU 2002230965 A AU2002230965 A AU 2002230965A AU 2002230965 A AU2002230965 A AU 2002230965A AU 2002230965 A8 AU2002230965 A8 AU 2002230965A8
Authority
AU
Australia
Prior art keywords
methods
inhibiting fibrosis
fibrosis
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002230965A
Other versions
AU2002230965A1 (en
Inventor
Denise L Faustman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU2002230965A1 publication Critical patent/AU2002230965A1/en
Publication of AU2002230965A8 publication Critical patent/AU2002230965A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
AU2002230965A 2000-12-15 2001-12-17 Methods for inhibiting fibrosis Abandoned AU2002230965A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/255,728 2000-08-16
US25572800P 2000-12-15 2000-12-15
PCT/US2001/048811 WO2002047540A2 (en) 2000-12-15 2001-12-17 Methods for inhibiting fibrosis

Publications (2)

Publication Number Publication Date
AU2002230965A1 AU2002230965A1 (en) 2002-06-24
AU2002230965A8 true AU2002230965A8 (en) 2009-07-30

Family

ID=

Also Published As

Publication number Publication date
WO2002047540A2 (en) 2002-06-20
WO2002047540A3 (en) 2009-06-11
AU3096502A (en) 2002-06-24

Similar Documents

Publication Publication Date Title
GB0016459D0 (en) Method
AU7090201A (en) Method
GB0009353D0 (en) Method
GB0026390D0 (en) Method
GB0028108D0 (en) Method
GB0005867D0 (en) Method
GB0025132D0 (en) Method
GB0024884D0 (en) Method
GB0007873D0 (en) Method
GB0018039D0 (en) Method
AU2002230965A8 (en) Methods for inhibiting fibrosis
GB0022330D0 (en) Method
AU2002230965A1 (en) Methods for inhibiting fibrosis
GB0013260D0 (en) Method
GB0007872D0 (en) Method
GB0009762D0 (en) Method
GB0019295D0 (en) Method
GB0006853D0 (en) Method
GB0006590D0 (en) Method
GB0008348D0 (en) Method
GB0009148D0 (en) Method
GB0006034D0 (en) Method
GB0003837D0 (en) Method
GB0012280D0 (en) Method
GB0003440D0 (en) Method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase